Diligence memo · auto-generated · as of July 2, 2026
Amplitude Vascular Systems, Inc.
Amplitude Vascular Systems, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Amplitude Vascular Systems, Inc. operates in Software / Tech, based in Boston.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Amplitude Vascular Systems, Inc. has raised $29M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $24M on 2024-10-15.
Most recent recorded round closed around 2024-10-15.
Valuation (modeled)modeled
Provath models Amplitude Vascular Systems, Inc. at approximately $160M (range $58M–$270M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.78× the median modeled value of Series B Software / Tech companies in 2022–2024 (174 peers) — value vs value, same stage and era. Within the normal band (78% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 26 months.
Last raise 21 mo ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
The last round stepped up 5.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 85% of Software / Tech peers (3920 compared).
Modeled value ranks above 80% of those peers.
Closest niche peers: Argyle Systems Inc., Shoreline Software, Inc., ALICE Technologies, Inc., Tint Technologies Inc., Vanilla Technologies Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.